Zai Lab (ZLAB) Net Cash Flow (2018 - 2026)
Zai Lab (ZLAB) posted Net Cash Flow of -$28.6 million for Q1 2026, up 24.16% sequentially from -$37.7 million in Q4 2025, and down 109.31% YoY from $307.6 million in Q1 2025.
Analysis
Zai Lab (ZLAB) Net Cash Flow (2018 - 2026) Analysis & Trends
Zai Lab has reported Net Cash Flow for 9 years, with the latest figure at -$28.6 million in Q1 2026.
- Quarterly Net Cash Flow fell 109.31% year-over-year to -$28.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$106.8 million (down 200.1% YoY) and the FY2025 annual result came in at $229.4 million, up 195.53% from the prior year.
- Net Cash Flow grew to -$28.6 million in Q1 2026 per ZLAB's latest filing, from -$37.7 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $442.6 million in Q3 2022 and troughed at -$165.7 million in Q4 2024.
- A 5-year average of -$12.0 million and a median of -$28.6 million in 2026 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2024 and 2025: Net Cash Flow tumbled 247229.85% in 2024, then soared 883.31% in 2025.
- Over 5 years, Net Cash Flow stood at -$113.9 million in 2022, then surged by 99.94% to -$67000.0 in 2023, then sank by 247229.85% to -$165.7 million in 2024, then jumped by 77.22% to -$37.7 million in 2025, then advanced by 24.16% to -$28.6 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$28.6 million, -$37.7 million, and -$15.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -183.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 407.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -496,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Zai Lab | 2.94 Bn | 2.23 Bn | 58.15 Mn | -46.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -46.12 Mn |
| Mar 31, 2026 | -28.63 Mn |
| Dec 31, 2025 | -37.75 Mn |
| Sep 30, 2025 | -15.30 Mn |
| Jun 30, 2025 | -25.10 Mn |
| Mar 31, 2025 | 307.58 Mn |
| Dec 31, 2024 | -165.71 Mn |
| Sep 30, 2024 | -14.50 Mn |
| Jun 30, 2024 | -20.70 Mn |
| Mar 31, 2024 | -39.27 Mn |
| Dec 31, 2023 | -67,000.00 |
| Sep 30, 2023 | -70.70 Mn |
| Jun 30, 2023 | -17.49 Mn |
| Mar 31, 2023 | -127.13 Mn |
| Dec 31, 2022 | -113.86 Mn |
| Sep 30, 2022 | 442.64 Mn |
| Jun 30, 2022 | -161.12 Mn |
| Mar 31, 2022 | -117.01 Mn |
| Dec 31, 2021 | -434.76 Mn |
| Sep 30, 2021 | -367.74 Mn |